Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Drugmaker stocks lead sector with healthy dividends
03:50pm, Friday, 23'rd Sep 2022
CNBC's Bertha Coombs reports on health care stocks.
Health care stocks with dividend yields to weather through market turmoil
09:19am, Friday, 23'rd Sep 2022
The healthcare sector is an investor favorite in a defensive market. CNBC's Bertha Coombs joins 'Squawk Box' to break down some players with the best dividend yields.
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
01:14pm, Thursday, 22'nd Sep 2022
Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris over an ingredient used in diabetes meds. The post Merck Stock Surges After Winning Patent Battle V
Viatris Inc.'s (VTRS) BofA Global Research Global Healthcare Conference Transcript
04:38pm, Thursday, 15'th Sep 2022
Viatris Inc. (NASDAQ:VTRS ) BofA Global Research Global Healthcare Conference September 15, 2022 11:45 AM ET Company Participants Michael Goettler – Chief Executive Officer Rajiv Malik – President
7 Screaming Buy Stock Picks to Beat the September Market Slump
06:30am, Tuesday, 13'th Sep 2022
Finding stock picks to beat the market are rare finds nowadays. In September stock markets began on downbeat momentum following the S&P 500 rally throughout the summer.
Is Viatris Stock a Buy Now?
10:00am, Monday, 12'th Sep 2022
Its top-line troubles could be transient, but there's a risk they won't be.
Making Healthcare More Efficient Could Benefit Select ETFs
11:40am, Wednesday, 07'th Sep 2022
The U.S. doesn't have nationalized healthcare comparable to some other developed countries, and it is home to one of the most lumbering, inefficient healthcare systems. It would be to the benefit of h
Viatris: 5% Dividend Yield Is A Threat For Investors
10:36pm, Monday, 05'th Sep 2022
Viatris's total revenue was $4,116.8 million in Q2 2022, down 10.1% year-on-year. Sales of the company's branded medicines have been declining since the formation of Viatris in 2020.
3 of the Best Dividend Stocks to Buy in September
10:00am, Wednesday, 31'st Aug 2022
From healthcare to oil and gas to telecom, these stocks can also help diversify your portfolio.
This Beaten-Down Dividend Stock Is a Scorching-Hot Buy
10:53am, Friday, 19'th Aug 2022
Viatris reported encouraging earnings numbers earlier this month.
Should I sell Viatris shares after Q2 results failed to meet revenue expectations?
06:56am, Sunday, 14'th Aug 2022
Viatris Inc. (NASDAQ: VTRS) reported its second-quarter results on Monday and lowered the revenue outlook for the 2022 fiscal year. Michael Goettler, CEO of Viatris, said that because of strong operat
10 defensive stocks that can also provide you with growth and dividends over the long term
10:05am, Wednesday, 10'th Aug 2022
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
Viatris' (VTRS) Q2 Earnings Beat, Revenues Miss Estimates
12:03pm, Monday, 08'th Aug 2022
Viatris (VTRS) beats on Q2 earnings but misses sales estimates. The company is on track to close its biosimilars deal with Biocon Biologics in the second half.
Viatris Inc. (VTRS) CEO Michael Goettler on Q2 2022 Results - Earnings Call Transcript
10:24am, Monday, 08'th Aug 2022
Viatris Inc. (NASDAQ:VTRS ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Bill Szablewski - Head of Global Capital Markets Michael Goettler - Chief Executive Officer
Viatris (VTRS) Surpasses Q2 Earnings Estimates
09:47am, Monday, 08'th Aug 2022
Viatris (VTRS) delivered earnings and revenue surprises of 8.64% and 0.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
